Medline Inc. has initiated a voluntary field action to remove, discontinue, and exit the market for all of its Medline Brand beds. The action, which began on October 14, 2026, includes homecare, bariatric, and long-term care beds, along with associated parts and accessories.
Key Details
- Affected Revenue: The products being discontinued generated approximately $60 million in net sales for the twelve months ended June 27, 2026.
- Estimated Costs: The company estimates total costs associated with the market exit, including inventory impairment and customer credits, of up to $220 million, expected to be incurred in 2026 and 2027.
- Financial Outlook: Medline stated that it does not expect this action to have a material impact on its financial results or its full-year guidance for fiscal year 2026.